Comprehensive Hereditary Cancer Risk Asessment
At our state-of-the-art, CLIA certified and COLA accredited facility we perform Next Generation Sequencing (NGS) based screening for mutations known to affect an individual’s risk of developing hereditary cancer. Results from the PREDICT™ test enable the physician to make better informed treatment decisions.
LabSolutions is pleased to offer its clients a comprehensive suite of genetic tests, allowing the physicians we serve to provide truly personalized healthcare. Coupling the latest in laboratory technologies with highly trained genomic scientists and counselors keeps our clients on the cutting edge of molecular science. Next Generation Sequencing (NGS) based screening for mutations known to affect an individual’s risk of developing hereditary cancer is performed at our state-of-the-art, CLIA certified and COLA accredited facility. PREDICT™ test results, along with an ordering and treating provider’s expertise, are used to make better informed clinical decisions.
Hereditary or Predisposition Cancer Genomics
Molecular testing looks for specific inherited changes (mutations) in a person’s genetic make-up. Genetic mutations may have multiple different effects on a patient’s health. Mutations that are harmful may increase a person’s chance, or risk, of developing a disease such as cancer. Inherited mutations are thought to play a role in 5-10% of all cancers. These particular conditions are considered hereditary and appropriate genetic testing may be used to determine an individual’s risk.
Some people inherit mutation(s) in the germline, allowing for the mutations to be passed on from their parents and to their children. There are two classes of cellular genes: oncogenes and tumor suppressor genes. Often, multiple genetic mutations in a single individual are responsible for the development of hereditary cancers.
Cancer is a disorder in which the normal control of cell growth is lost, causing abnormal proliferation of the affected cells. Inherited genetic mutations may increase a patient’s risk of developing cancer through numerous mechanisms, depending on the aberrant functions of the mutated parent gene. Mutations in genes involved in mismatched repair of damaged DNA are particularly likely to lead to a higher cancer risk.
COMMON HEREDITARY CANCERS AND CANCER SYNDROMES
Lynch Syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM)
Colon Cancer (APC, BMPR1A, EPCAM)
Uterine Cancer (MLH1, MSH2, EPCAM, MSH6, PMS2)
Endometrial Cancer (EPCAM, MLH1, MSH2, MSH6)
Li-Fraumeni Syndrome (TP53)
Breast and Ovarian Cancer (BRCA1, BRCA2)
FAMILY RISK INSIGHT
WHY SHOULD PATIENTS GET TESTED?
- Cancer that occurs in unusually young ages
- Multiple childhood cancers in siblings
- Cancer occurring in an unusual gender (e.g., breast cancer in male family members)
- Multiple cancers in a single person
- Cancer in organ pairs (e.g., cancers in both kidneys)
- Rare cancers occurring in multiple members of the family
- Starting cancer screening tests earlier
- Getting screened for that type of cancer more often
- Watching themselves closely for signs or symptoms of that kind of cancer
- Lifestyle changes
- Preventive medications or surgery if recommended by a healthcare provider